Chad Gassert, SVP - Corporate Development & STRATEGY at ANI PHARMACEUTICALS INC (ANIP), sold 20,000 shares at $56.48 ($1.1M) on 2023-10-02, disclosed to the SEC on 2023-10-03.
Scheduled sale ($1.1M) by SVP - Corporate Development & STRATEGY under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ANIP | SELL | 2024-07-02 | $1.3M | — | Filing → |
| ANIP | SELL | 2024-06-04 | $1.3M | — | Filing → |
| ANIP | SELL | 2024-05-03 | $1.3M | — | Filing → |